Europe L-Carnosine Market Trends, Future Outlook, COVID-19 Impact Analysis, Forecast 2022-2028
Europe
L-carnosine market is estimated to grow at a CAGR of around 4.3% during the
forecast period. The market is driven by
increasing diabetes, eye disorders (cataracts), and kidney-related disorders.
There is a growing demand for L-carnosine for the prevention and treatment of
complications associated with diabetes such as nerve damage, and eye disorders
(cataracts). Therefore, the increasing prevalence of diabetes is one of the
primary factors which is contributing to the growth of the market. According to
IDF Europe, in 2018, more than 58 million diabetic people were living in
Europe; this number is expected to reach 66.7 million by 2045. This trend
suggests that the demand for L-carnosine in Europe will increase significantly
in the near future.
To learn more about this report request a sample
copy @ https://www.omrglobal.com/request-sample/europe-l-carnosine-market
Europe
L-carnosine market is segmented on the basis of application and geography.
Based on the application, the market is segmented into autism, diabetes
support, skin support, CVD support, joint support, and others. Others segment
include digestion support, Parkinson’s disease, and Alzheimer’s disease. In
2019, the skin support segment is projected to contribute a significant share
to the global market.
Moreover,
the report covers the country-level analysis of the Europe L-carnosine market.
The economies covered in the report studied include UK, Germany, Italy, Spain,
France, and the Rest of Europe. UK L-carnosine market is estimated to grow
significantly during the forecast period. The growth is attributed to the
increasing incidence and prevalence rate of chronic diseases, such as CVDs
(cardiovascular diseases) and diabetes. The prevalence of diabetes has changed
significantly in the UK. It has increased from a year on year growth of 2.9% to
7.6% among men between the period 1994-2016, and 1.9% to 2.6% among women in
the same period.
L-carnosine
market players are making efforts to develop L-carnosine products for various
purposes such as managing aging and cardiovascular health & cellular
protection. Bachem AG is a Switzerland-based company offering more than 5,500
different biologically active peptides, amino acid derivatives, and
biochemicals through its online portal. It has a global reach with the
subsidiaries in the US, UK, and Japan. Moreover, the company has distributors network
in Austria, Belgium, Brazil, Canada, France, Germany, India, Italy, Luxembourg,
the Netherlands, Spain, and Taiwan. The company offers L-carnosine in a pack
size of 5 gm and 25 gm. The list price of 5 gm L-carnosine is $194, and $826
for 25 gm packs.
Europe L-Carnosine Market- Segmentation
By
Application
·
Autism
·
Diabetes
·
Skin Support
·
Cardiovascular Support
·
Joint Support
·
Others
A full report of Europe L-Carnosine Market is
available at: https://www.omrglobal.com/industry-reports/europe-l-carnosine-market
Europe L-Carnosine Market– Segment by Region
·
Germany
·
United Kingdom
·
France
·
Spain
·
Italy
·
Rest of Europe
Company Profiles
·
Bachem AG
·
Cambridge
Bioscience Ltd.
·
Jarrow Formulas,
Inc.
·
Kirkman Group, Inc.
·
Merck KGaA
·
NOW Foods, LLC
·
Quest Vitamins Ltd.
·
ZeinPharma Germany
GmbH
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments